Dr. Malorie K Morris Dentist Medicare: Not Enrolled in Medicare Practice Location: 9449 Mill Creek Road, Chester, IL 62233 Phone: 618-615-1296 |
Dr. Melaina Hope Hess, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1654 State St, Chester, IL 62233 Phone: 618-826-5017 |
Robert Charles Franklin, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1654 State St, Chester, IL 62233 Phone: 618-826-5017 |
Dr. Patrick D Miller, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1654 State St, Chester, IL 62233 Phone: 618-826-5017 |
Dr. Philip Anthony Miller, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1654 State St, Chester, IL 62233 Phone: 618-826-5017 |
Dr. Robert Louis Platt, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2321 Old Plank Rd, Chester, IL 62233 Phone: 618-826-5416 Fax: 618-826-1460 |
News Archive
Vitalitec International, Plymouth, Massachusetts, is pleased to announce the acquisition of the ENCLOSE II Anastomosis Assist Device from Novare Surgical Systems. The ENCLOSE II Anastomosis Assist Device was developed by Thomas Fogarty, MD, and is designed to assist surgeons in performing "off pump" Coronary Artery Bypass Procedures.
Yale researchers report the first evidence that phantom pain following spinal cord injury is the result of hypersensitive neurons in the thalamic region of the brain that can be suppressed with specially designed molecular agents.
Cardiovascular disease, including heart disease and stroke, are among the top killers worldwide. Ischemic heart disease and stroke are the world's major killers, accounting for 15.2 million deaths in 2016. A high triglyceride level, combined with high low-density lipoprotein (LDL) cholesterol, is linked to atherosclerosis, which increases the risk for heart attack and stroke.
Waters Corporation announced that it entered into a Co-Marketing agreement with Wyatt Technology to advance the analysis of synthetic polymers and biotherapeutic proteins.
Interim findings from a clinical trial (PREVAIL) in which two experimental Ebola vaccines were given to more than 600 people in Liberia indicate that the vaccines are safe for use in humans. Based on these positive results, the vaccines may continue into the next stage of clinical evaluation; a phase 3 trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
› Verified 4 days ago